| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/NEU.2015.18 |
| P698 | PubMed publication ID | 25858158 |
| P50 | author | Joseph Quinn | Q40301777 |
| Randall L Woltjer | Q67221637 | ||
| P2093 | author name string | Jeffrey A Kaye | |
| Paul L Wood | |||
| Brooke L Barnette | |||
| P2860 | cites work | SLC27 fatty acid transport proteins | Q24601518 |
| The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors | Q24602845 | ||
| Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial | Q24607545 | ||
| Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging | Q28477836 | ||
| Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study | Q28943540 | ||
| Application of a novel metabolomic approach based on atmospheric pressure photoionization mass spectrometry using flow injection analysis for the study of Alzheimer's disease | Q33463049 | ||
| Peroxisomal alterations in Alzheimer's disease | Q33905478 | ||
| Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry | Q33947437 | ||
| Molecular reorganization of endocannabinoid signalling in Alzheimer's disease | Q34754667 | ||
| Age, Alzheimer's disease, and the big picture | Q35660351 | ||
| Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. | Q35710041 | ||
| Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology | Q36112830 | ||
| Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease | Q36604677 | ||
| Diacylglycerol, when simplicity becomes complex. | Q36678145 | ||
| Factors associated with resistance to dementia despite high Alzheimer disease pathology | Q37180466 | ||
| Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer's disease: an early event in disease pathogenesis. | Q37351086 | ||
| Neuropathologic basis of white matter hyperintensity accumulation with advanced age. | Q37463581 | ||
| Lipidomics of Alzheimer's disease: current status | Q37980283 | ||
| Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease | Q38106483 | ||
| Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain | Q42557209 | ||
| Lipidomics reveals dysfunctional glycosynapses in schizophrenia and the G72/G30 transgenic mouse | Q43548986 | ||
| Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis | Q44163309 | ||
| Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. | Q44963304 | ||
| Stimulation of lipolytic enzymes in alzheimer's disease | Q48101825 | ||
| Mixed brain pathologies account for most dementia cases in community-dwelling older persons | Q48136681 | ||
| Regional levels of brain phospholipase Cgamma in Alzheimer's disease. | Q48356519 | ||
| Phospholipase C isozymes in the human brain and their changes in Alzheimer's disease. | Q48534380 | ||
| The amyloid cascade hypothesis. | Q49075559 | ||
| Alzheimer's changes in non-demented and demented patients. | Q53312536 | ||
| Shotgun lipidomics on a LTQ Orbitrap mass spectrometer by successive switching between acquisition polarity modes | Q83335527 | ||
| Immunotherapy for Alzheimer's disease | Q87164388 | ||
| P433 | issue | 5 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| mild cognitive impairment | Q1472703 | ||
| cognitive dysfunction | Q57859955 | ||
| P304 | page(s) | 270-278 | |
| P577 | publication date | 2015-04-10 | |
| P1433 | published in | Acta Neuropsychiatrica | Q4676734 |
| P1476 | title | Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects | |
| P478 | volume | 27 |
| Q36538782 | Amelioration of Metabolic Syndrome-Associated Cognitive Impairments in Mice via a Reduction in Dietary Fat Content or Infusion of Non-Diabetic Plasma. |
| Q97882327 | Analytical challenges of shotgun lipidomics at different resolution of measurements |
| Q64968111 | Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy Body Disease |
| Q99710861 | Blood biomarkers indicate that the preclinical stages of Alzheimer's disease present overlapping molecular features |
| Q99635766 | Brain region-specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer's disease |
| Q101038830 | Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain-Barré syndrome |
| Q34552659 | Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial |
| Q48159157 | From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system. |
| Q58723601 | High-Throughput Direct Mass Spectrometry-Based Metabolomics to Characterize Metabolite Fingerprints Associated with Alzheimer's Disease Pathogenesis |
| Q52688310 | Lipidomic analysis of immune activation in equine leptospirosis and Leptospira-vaccinated horses. |
| Q38740021 | Lipidomics: Prospects from a technological perspective. |
| Q38803730 | Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences |
| Q89879977 | Lipids and Alzheimer's Disease |
| Q42655692 | Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses |
| Q36990153 | Neuronal human BACE1 knockin induces systemic diabetes in mice. |
| Q39320214 | Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention. |
| Q26774697 | Peroxisomes in brain development and function |
| Q47132185 | Plasma lipidomics of tuberculosis patients: altered phosphatidylcholine remodeling |
| Q64109669 | Plasmalogens and Alzheimer's disease: a review |
| Q41934251 | Targeted Lipidomics of Fontal Cortex and Plasma Diacylglycerols (DAG) in Mild Cognitive Impairment and Alzheimer's Disease: Validation of DAG Accumulation Early in the Pathophysiology of Alzheimer's Disease |
| Q36713818 | Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD). |
| Q90382535 | The Effects of Doxorubicin-based Chemotherapy and Omega-3 Supplementation on Mouse Brain Lipids |
| Q36209750 | The Effects of Long-Term Saturated Fat Enriched Diets on the Brain Lipidome. |
Search more.